COVID-19 mRNA Booster Vaccine Safety Study
Part of Infections, Lungs & breathing clinical trials.
This trial tests a new mRNA COVID-19 booster vaccine made by a Brazilian research institute. Researchers want to confirm it's safe and well-tolerated in adults who have already received previous COVID-19 vaccines.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 59 years old
- You have completed a full COVID-19 vaccination series plus at least one booster dose (all mRNA-based), with the last booster at least 6 months ago
- You currently test negative for COVID-19 and have not had COVID symptoms recently
- Your weight is at least 50 kg (men) or 45 kg (women), and your BMI is between 19 and 35
- You have no serious medical conditions like heart problems, immune system disorders, or recent cancer
- You agree to use birth control if you could become pregnant, and you're not currently pregnant or breastfeeding
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new type of COVID-19 booster vaccine that targets a protein to help your immune system. It's for people who already had a primary vaccine series and at least one mRNA booster, with the last booster at least 6 months ago.
This study tests new COVID-19 booster vaccine candidates in healthy adults who previously received mRNA COVID-19 vaccines. Researchers will monitor safety and how well your immune system responds to help develop better COVID-19 protection.
This Phase 3 trial tests a booster vaccine made from a three-part COVID-19 protein (aimed at XBB, BA.5, and Delta) to see how well it works and is tolerated. It may help adults who are due for a COVID-19 booster, including people with certain health conditions, depending on screening results.
This Phase 2 study tests a booster vaccine made from a COVID-19 protein (XBB + prototype) to help your immune system respond better. You may be able to join if you’re an adult who is due for a booster and meets health and safety screening checks.
This trial tests updated COVID-19 vaccines designed to better protect against current variants. It's for people who have already been vaccinated and are at higher risk for severe COVID-19.
This study tests a new type of COVID-19 vaccine that is designed to train your immune system to make stronger, longer-lasting protection. You may be able to join if you are 40–64, have already had at least two doses of a mRNA COVID-19 vaccine (Pfizer or Moderna) more than 4 months ago, and are generally healthy.
Hear when a new Severe Acute Respiratory Syndrome (SARS-CoV-2 Virus) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.